|
Name |
Type |
Discontinued? |
|
| 1 |
RESULT_ID |
VARCHAR |
No |
|
|
|
| The unique identifier for the result record. |
|
|
| 2 |
CAP_COMMENTS |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: General comments. |
|
|
| 3 |
SPECIMEN_WEIGHT |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Specimen Weight. |
|
|
| 4 |
SPEC_PROC_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify the Specimen Procedure. |
|
|
| 5 |
TUMOR_SIZE_GREAT |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Greatest Size. |
|
|
| 6 |
TUMOR_SIZE_ADDL |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size (length). |
|
|
| 7 |
TUMOR_SIZE_ADDL2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size (width). |
|
|
| 8 |
HISTO_TYPE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify histologic type. |
|
|
| 9 |
PERINEURAL_INVASN_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Perineural Invasion. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Cannot be assessed |
| Not identified |
| Absent |
| Present |
| Indeterminate |
| Portal vein invasion present |
| Hepatic vein invasion present |
| Present within tumor nodules |
| Present in vessels of parenchyma outside of tumor nodules |
| Cannot be determined |
|
|
| 10 |
SEMINAL_VESICLE_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Seminal Vesicle Invasion. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not identified |
| Present |
| No seminal vesicle present |
|
|
| 11 |
PERIPROSTATIC_FAT_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Periprostatic Fat Invasion. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not identified |
| Present |
|
|
| 12 |
ADDL_PATH_FIND_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify additional pathologic findings. |
|
|
| 13 |
HISTOLOGIC_GRADE_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Histologic Grade. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not applicable |
| GX: Cannot be assessed |
| G1: Well differentiated |
| G2: Moderately differentiated |
| G3: Poorly differentiated |
| G4: Undifferentiated |
| G4: Undifferentiated / anaplastic |
| WHO grade not assigned |
| Low-grade (well-differentiated to moderately differentiated) |
| High-grade (poorly differentiated to undifferentiated) |
| FIGO Grade 1 |
| FIGO Grade 2 |
| FIGO Grade 3 |
| Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in |
| Less favorable (all subtypes other than those designated "Favorable" or "Unfavorable" |
| Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo |
| Gleason Pattern |
| Ungraded sarcoma |
| pGX: Grade cannot be assessed |
| pG1: Spindle cell melanoma |
| pG2: Mixed cell melanoma |
| pG3: Epithelioid cell melanoma |
| WHO Grade I |
| WHO Grade II |
| WHO Grade III |
| WHO Grade IV |
| pG1: Well differentiated |
| pG2: Moderately differentiated |
| pG3: Poorly differentiated |
| pG4: Undifferentiated |
| FNCLCC Grade 1 |
| FNCLCC Grade 2 |
| FNCLCC Grade 3 |
| Grade 1 |
| Grade 2 |
| Grade 3 |
| Cannot be determined |
| Other |
|
|
| 14 |
PRIMARY_GLEASON_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Primary Gleason Pattern. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Grade 1 |
| Grade 2 |
| Grade 3 |
| Grade 4 |
| Grade 5 |
|
|
| 15 |
SECONDARY_GLEASON_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Secondary Gleason Pattern. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Grade 1 |
| Grade 2 |
| Grade 3 |
| Grade 4 |
| Grade 5 |
|
|
| 16 |
TOTAL_GLEASON_SCORE |
INTEGER |
No |
|
|
|
| CAP synoptic form item: Total Gleason Score. |
|
|
| 17 |
NUM_POSITIVE_CHIPS |
INTEGER |
No |
|
|
|
| CAP synoptic form item: Number of Positive Chips. |
|
|
| 18 |
TOTAL_NUM_CHIPS |
INTEGER |
No |
|
|
|
| CAP synoptic form item: Total Number of Chips. |
|
|
| 19 |
PATH_INFLAM_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Additional Pathological Findings - Specify Inflammation. |
|
|
| 20 |
SPECIMEN_SIZE_SPEC1 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Specimen Size Specify. |
|
|
| 21 |
SPECIMEN_SIZE_SPEC2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Specimen Size Specify 2. |
|
|
| 22 |
SPECIMEN_SIZE_SPEC3 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Specimen Size Specify 3. |
|
|
| 23 |
TUR_SPEC_PROPORTION |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: TUR Specimens - Proportion (%) of prostatic tissue involved by tumor. |
|
|
| 24 |
ENU_SPEC_PROPORTION |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Enucleation Specimens - Proportion (%) of prostatic tissue involved by tumor. |
|
|
| 25 |
TUR_SPE_TUMOR_QT_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: TUR Specimens - Tumor Quantitation. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Tmr histologic finding in no more than 5% of tissue resected with Gleason 2 to 6 |
| Tmr histologic finding in no more than 5% of tissue resected or Gleason 7 to 10 |
|
|
